Key points from article :
Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene targets. Previously took decades to find and study enough people with rare traits.
How DNA sequencing is transforming the hunt for new drugs
13-May-2015
Mentioned in this article:
Click on resource name for more details.
Eric Topol
Founder and director of the Scripps Research Translational Institute, American cardiologist, scientist and author
Read full article on Reuters website written by Julie Steenhuysen
